📹 ICYMI Reporting on Alcohol Webinar

Watch our conversation with STAT News journalists Isabella Cueto & Lev Facher

Share
📹 ICYMI Reporting on Alcohol Webinar
💡
Have ideas for future lunch & learn topics?
Reply to this email!

In August, we chatted with STAT News Reporters Isabella Cueto (Chronic Disease Reporter) and Lev Facher (Addiction Reporter) to learn more about how they approached their 8-part series on alcohol: The Deadliest Drug.

To quickly emphasize the impact of this reporting...on the day of our convo, the American Cancer Society cancelled its yearly alcohol industry fundraiser (paywalled💸). But that is only scratching the surface of how this type of reporting can help improve community health and well-being.

In this 30-minute conversation, we covered why they thought it was important to cover alcohol, how they approached source anonymity, story ideas for other reporters looking to cover alcohol, and more!

Speaker Bios

Isabella Cueto

Isabella Cueto is a reporter at STAT, where she writes about how the Trump administration is shaping people's health. She previously worked as a local reporter in California, South Carolina and Florida.

Isabella Cueto
Isabella Cueto is a chronic disease reporter writing about how the Trump administration is tackling the nation’s health epidemic — or not. She’s taken readers inside the world of MAHA, behind the scenes in Washington, out to a regenerative farm in Texas, and back into the lab.

Lev Facher

Lev Facher covers substance use and addiction for STAT. His reporting has explored Americans' deadly hostility to addiction medications, subpar treatment offered in jails and prisons, shifts in the illicit drug supply and consumption behavior, controversies surrounding harm reduction, and recent innovations in addiction medicine.

Lev Facher
Lev Facher covers substance use and addiction. His reporting has explored Americans’ deadly hostility to addiction medications, subpar treatment offered in jails and prisons, shifts in the illicit drug supply and consumption behavior, controversies surrounding harm reduction, and recent innovations in addiction medicine.